Maybelline compact powder foundation light beige
Maybelline compact powder foundation light beige
Couldn't load pickup availability
Maybelline Superstay 24H Powder Foundation 9g No. 10 provides buildable coverage and a long-lasting matte finish. Its lightweight texture allows for even application for a natural, even complexion all day long.
- Adjustable coverage suitable for all skin types
- Matte finish and hold for up to 24 hours
- Light texture for easy application and skin comfort
- Suitable for everyday use
Pick up a small amount of powder using a sponge or suitable brush, then apply evenly all over the face, paying particular attention to the T-zone. Can be used alone or over liquid foundation to increase coverage. Avoid direct contact with eyes. Close tightly after use.
Talc, Synthetic Fluorphlogopite, Silica, Nylon-12, Boron Nitride, Dimethicone, Magnesium Myristate, Octyldodecyl Stearoyl Stearate, Trimethylsiloxysilicate, Caprylyl Glycol, Ethylhexylglycerin, Phenoxyethanol, Tocopherol, [+/- May Contain: CI 77891 (Titanium Dioxide), CI 77491, CI 77492, CI 77499 (Iron Oxides)]. For the full list of ingredients, see package insert.
Legal notices:
The information on this product sheet is provided for information purposes only, in accordance with Regulation (EC) No. 1924/2006 on nutrition and health claims made on foodstuffs, and Article L. 111-1 of the French Consumer Code.
They cannot in any case constitute a medical prescription nor replace the consultation of a qualified health professional. Any use of the product must comply with the instructions, the recommended dosage, and the precautions for use.
In accordance with Article L. 5122-15 of the Public Health Code, Groupe Nobélis SASU declines all responsibility in the event of misuse, self-medication or non-compliance with official recommendations.
Photographs, descriptions, and technical information are non-contractual and are subject to change at any time. The user is encouraged to regularly check for updates or contact a healthcare professional for any treatment-related questions.
Share
